1. Home
  2. FISN vs SLS Comparison

FISN vs SLS Comparison

Compare FISN & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Deep Fission Inc. Common Stock

FISN

Deep Fission Inc. Common Stock

N/A

Current Price

$6.53

Market Cap

386.4M

Sector

Utilities

ML Signal

N/A

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$13.41

Market Cap

924.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FISN
SLS
Founded
N/A
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
386.4M
924.5M
IPO Year
2025
2007

Fundamental Metrics

Financial Performance
Metric
FISN
SLS
Price
$6.53
$13.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
203.9K
6.4M
Earning Date
N/A
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
98.25
50.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$110.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.76
$1.39
52 Week High
$15.50
$15.88

Technical Indicators

Market Signals
Indicator
FISN
SLS
Relative Strength Index (RSI) 33.79 55.17
Support Level N/A $11.43
Resistance Level $9.05 $15.77
Average True Range (ATR) 0.62 1.19
MACD -0.06 0.14
Stochastic Oscillator 9.17 62.22

Price Performance

Historical Comparison
FISN
SLS

About FISN Deep Fission Inc. Common Stock

Deep Fission Inc is a nuclear energy technology company developing a small modular reactor based on established pressurized water reactor technology, with novel emplacement in deep boreholes approximately one mile below the Earth's surface. Its reactor, which is referred to as the Gravity Reactor, will leverage subsurface conditions to support key containment and operating functions, including the use of hydrostatic pressure from a water column within the borehole to support reactor operating pressure and cooling, and the surrounding geological formation to provide structural confinement and shielding. The group's focus is within the United States, where electricity demand growth, expanding digital infrastructure, and evolving energy policy.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: